Mycophenolate mofetil and Reflux nephropathy - a phase IV clinical study of FDA data

Summary:

Reflux nephropathy is reported as a side effect among people who take Mycophenolate mofetil (mycophenolate mofetil), especially for people who are female, 50-59 old, have been taking the drug for 1 - 6 months also take Empagliflozin, and have Diabetes.

The phase IV clinical study analyzes which people have Reflux nephropathy when taking Mycophenolate mofetil. It is created by eHealthMe based on reports of 93,176 people who have side effects when taking Mycophenolate mofetil from the FDA, and is updated regularly.

What is Mycophenolate mofetil?

Mycophenolate mofetil has active ingredients of mycophenolate mofetil. It is often used in myasthenia gravis. eHealthMe is studying from 93,461 Mycophenolate mofetil users. Check the latest studies of Mycophenolate mofetil.

What is Reflux nephropathy?

Reflux nephropathy (when urine goes back up the wrong way from the bladder towards the kidney) is found to be associated with 89 drugs and 359 conditions by eHealthMe. Check the latest studies of Reflux nephropathy.

On Aug, 06, 2026

93,176 people reported to have side effects when taking Mycophenolate mofetil.
Among them, 40 people (0.04%) have Reflux nephropathy.

Could Mycophenolate mofetil cause Reflux nephropathy?

Among these 40 people:

How long have people been on Mycophenolate mofetil when they have Reflux nephropathy? *

What is the gender of people who have Reflux nephropathy when taking Mycophenolate mofetil? *

female: 82.5 %
male: 17.5 %

What is the age of people who have Reflux nephropathy when taking Mycophenolate mofetil? *

What are other drugs people take besides Mycophenolate mofetil? *

Empagliflozin: 15 people, 37.50%
Envarsus Xr: 12 people, 30.00%
Tacrolimus: 9 people, 22.50%
Insulin: 9 people, 22.50%
Methylprednisolone: 8 people, 20.00%
Prograf: 8 people, 20.00%
Piperacillin And Tazobactam: 8 people, 20.00%
Amphotericin B: 6 people, 15.00%
Meropenem: 6 people, 15.00%
Prednisone: 6 people, 15.00%

What are other side effects people have besides Reflux nephropathy? *

Urinary Tract Infection: 24 people, 60.00%
Renal Impairment (severely reduced kidney function): 17 people, 42.50%
Urinary Tract Infection Enterococcal: 16 people, 40.00%
Candida Sepsis (candida in blood stream): 15 people, 37.50%
Septic Shock (shock due to blood infection): 15 people, 37.50%
Systemic Candida (whole body fungal infection): 15 people, 37.50%
Bleeding Disorders: 15 people, 37.50%
Emphysematous Pyelonephritis (presence of gas-producing bacteria in the kidney): 15 people, 37.50%
Perinephric Abscess: 15 people, 37.50%
Urine Output - Decreased: 15 people, 37.50%

What are the existing conditions these people have? *

Diabetes: 16 people, 40.00%
Emphysematous Pyelonephritis (presence of gas-producing bacteria in the kidney): 12 people, 30.00%
Histology Abnormal: 4 people, 10.00%
Thrombotic Microangiopathy (a pathology that results in thrombosis in capillaries and arterioles, due to an endothelial injury): 2 people, 5.00%
Pyelonephritis Fungal (inflammation of kidney caused by fungal infection): 2 people, 5.00%
Kidney Transplant Rejection: 2 people, 5.00%
Immunodeficiency Disorders: 2 people, 5.00%
Immune Tolerance Induction: 2 people, 5.00%
Hyperparathyroidism (an abnormally high concentration of parathyroid hormone in the blood, resulting in weakening of the bones through loss of calcium): 2 people, 5.00%
High Blood Pressure: 2 people, 5.00%

* Approximation only. Some reports may have incomplete information.

Do you take Mycophenolate mofetil and have Reflux nephropathy?

- Check whether Reflux nephropathy is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously

Related studies:

Effectiveness of, long term effects of, and alternative drugs to Mycophenolate mofetil:

Mycophenolate mofetil (93,461 reports)

Browse all side effects of Mycophenolate mofetil:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all the drugs that are associated with Reflux nephropathy:

Reflux nephropathy (89 drugs)

Browse all the conditions that are associated with Reflux nephropathy:

Reflux nephropathy (359 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on mycophenolate mofetil (the active ingredients of Mycophenolate mofetil) and Mycophenolate mofetil (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.